Envestnet Asset Management Inc. Acquires 94,768 Shares of Danaher Corporation $DHR

Envestnet Asset Management Inc. raised its holdings in Danaher Corporation (NYSE:DHR) by 7.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,355,964 shares of the conglomerate’s stock after acquiring an additional 94,768 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Danaher were worth $267,850,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Vanguard Group Inc. raised its holdings in Danaher by 0.4% in the first quarter. Vanguard Group Inc. now owns 59,981,088 shares of the conglomerate’s stock worth $12,296,123,000 after purchasing an additional 230,966 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in Danaher by 3.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 19,592,211 shares of the conglomerate’s stock worth $4,016,404,000 after purchasing an additional 612,154 shares during the period. Bank of New York Mellon Corp raised its holdings in Danaher by 2.3% in the first quarter. Bank of New York Mellon Corp now owns 8,783,485 shares of the conglomerate’s stock worth $1,800,614,000 after purchasing an additional 194,466 shares during the period. Invesco Ltd. raised its holdings in Danaher by 44.5% in the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock worth $965,259,000 after purchasing an additional 1,450,703 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in Danaher by 4.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 4,230,087 shares of the conglomerate’s stock worth $867,168,000 after purchasing an additional 163,332 shares during the period. 79.05% of the stock is owned by institutional investors.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 11.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have weighed in on DHR. Bank of America cut their target price on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a report on Monday, September 22nd. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a report on Friday. Redburn Partners set a $220.00 price objective on shares of Danaher in a report on Wednesday, October 8th. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective on the stock in a report on Friday, July 11th. Finally, Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $243.39.

Danaher Stock Up 0.1%

Danaher stock opened at $223.03 on Monday. The company has a market cap of $157.54 billion, a P/E ratio of 45.99, a price-to-earnings-growth ratio of 3.41 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The company has a fifty day simple moving average of $202.73 and a 200 day simple moving average of $198.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.